Self-Monitoring Blood Glucose Devices Market 2018-2024 key players Abbott Laboratories, Arkray, Inc., All Medicus Co., Bayer Healthcare, Bionime Corporation, Dexcom, Inc., ohnson & Johnson, Lifescan, Medtronic, Nova Biomedical

The Self-Monitoring Blood Glucose Devices Market report featuring key industry trends across the product, end-user, and regional landscape by Global Market Insights, Inc. says, the global self-monitoring blood glucose devices market revenue is poised to cross USD 20 billion by 2024.

The rapidly increasing number of diabetic patients across the globe are predicted to propel self-monitoring blood glucose devices market. As per estimates from the Diabetes Atlas of International Diabetes Federation, more than 629 million of the global populace between 20-79 years of age are expected to be afflicted with diabetes by the end of 2045.

Self-monitoring blood glucose devices market share from hospitals was worth USD 6.9 billion in 2017. As per the report, self-monitoring blood glucose devices industry size from hospitals is expected to register a CAGR of 4.6% over 2018-2024, driven by the growing prevalence of diabetes across the globe.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2743

U.S. emerged as a dominant region in the global self-monitoring blood glucose devices industry in 2017 with a contribution of 34.2% toward the overall share. Extensive expenditure on healthcare along with the ample availability of advanced healthcare infrastructure are poised to impel the regional industry.

The key players profiled in the report are Abbott Laboratories, All Medicus Co. Ltd., Arkray Inc., B. Braun Melsungen, Bayer Healthcare, Bionime Corporation, Dexcom Inc., F. Hoffmann-La Roche, Johnson & Johnson, LifeScan, Inc., Medtronic, Nipro Diagnostics, Nova Biomedical, Sinocare, Trividia Health. The companies have been profiled in terms of their product portfolio, SWOT analysis, and strategic outlook.

Browse key industry insights spread across 120 pages with 68 market data tables & 07 figures & charts from the report, “Self-Monitoring Blood Glucose Devices Market” in detail along with the table of contents:

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2743

The report also enumerates the challenges for the potential stakeholders which mainly includes high maintenance costs and strict regulatory norms related to the manufacturing of blood glucose monitoring devices.

Scope of the report:

• Self-monitoring blood glucose devices market product landscape: Self-Monitoring Blood Glucose Meters, Testing Strips, Continuous Glucose Monitors, Lancets

• Self-monitoring blood glucose devices market end-user landscape: Home Settings, Hospitals, Diagnostic Centers & Clinics

• Self-monitoring blood glucose devices market regional Landscape: Canada, U.S., Mexico, Italy, France, Russia, UK, Germany, Spain, Australia, China, South Korea, India, Japan, Brazil, Argentina, Saudi Arabia, UAE, Kuwait, South Africa

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://www.cmferesearch.com/

This release was published on openPR.